IL161599A0 - Method for the treatment of over-active bladder - Google Patents

Method for the treatment of over-active bladder

Info

Publication number
IL161599A0
IL161599A0 IL16159902A IL16159902A IL161599A0 IL 161599 A0 IL161599 A0 IL 161599A0 IL 16159902 A IL16159902 A IL 16159902A IL 16159902 A IL16159902 A IL 16159902A IL 161599 A0 IL161599 A0 IL 161599A0
Authority
IL
Israel
Prior art keywords
treatment
over
active bladder
bladder
active
Prior art date
Application number
IL16159902A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IL161599A0 publication Critical patent/IL161599A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16159902A 2001-11-02 2002-11-01 Method for the treatment of over-active bladder IL161599A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103668A SE0103668D0 (sv) 2001-11-02 2001-11-02 Method for the treatment of overactive blader
PCT/SE2002/001990 WO2003037341A1 (en) 2001-11-02 2002-11-01 Method for the treatment of overactive bladder

Publications (1)

Publication Number Publication Date
IL161599A0 true IL161599A0 (en) 2004-09-27

Family

ID=20285870

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16159902A IL161599A0 (en) 2001-11-02 2002-11-01 Method for the treatment of over-active bladder

Country Status (13)

Country Link
US (1) US20040248914A1 (enExample)
EP (1) EP1450805A1 (enExample)
JP (1) JP2005511561A (enExample)
KR (1) KR20050042211A (enExample)
CN (1) CN1622806A (enExample)
BR (1) BR0213776A (enExample)
CA (1) CA2465140A1 (enExample)
IL (1) IL161599A0 (enExample)
MX (1) MXPA04004071A (enExample)
NO (1) NO20042139L (enExample)
SE (1) SE0103668D0 (enExample)
WO (1) WO2003037341A1 (enExample)
ZA (1) ZA200403199B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121389A1 (en) * 2005-05-10 2006-11-16 Astrazeneca Ab Use of a neurokinin-2 receptor antagonist for treating or preventing detrusor overactivity
TWI667034B (zh) * 2016-09-21 2019-08-01 惠眾生技股份有限公司 關刀豆用於製備保護膀胱避免損傷藥劑之用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE300218B (enExample) * 1960-11-08 1968-04-22 Recip Ab
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles
GB9317104D0 (en) * 1993-08-17 1993-09-29 Zeneca Ltd Therapeutic heterocycles
US6008223A (en) * 1994-10-27 1999-12-28 Zeneca Limited Therapeutic compounds
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
GB9922519D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9924141D0 (en) * 1998-10-30 1999-12-15 Zeneca Ltd Treatment of gastric asthma
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence

Also Published As

Publication number Publication date
EP1450805A1 (en) 2004-09-01
BR0213776A (pt) 2004-11-09
ZA200403199B (en) 2005-02-09
CN1622806A (zh) 2005-06-01
KR20050042211A (ko) 2005-05-06
US20040248914A1 (en) 2004-12-09
SE0103668D0 (sv) 2001-11-02
NO20042139L (no) 2004-06-25
CA2465140A1 (en) 2003-05-08
JP2005511561A (ja) 2005-04-28
WO2003037341A1 (en) 2003-05-08
MXPA04004071A (es) 2004-09-06

Similar Documents

Publication Publication Date Title
HUS1600050I1 (hu) Eljárás szklerózis multiplex kezelésére
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
GB0512560D0 (en) Bioreactors for well treatment
GB0118373D0 (en) Novel therapeutic method
GB0129976D0 (en) Treatment method
GB0120147D0 (en) Treatment method
GB0124124D0 (en) Methods of treatment
GB0112216D0 (en) Method of treatment
IL155769A0 (en) Method for the treatment of inflammation
GB0118892D0 (en) Method of treatment
GB0222082D0 (en) Fluid treatment apparatus
GB0130763D0 (en) Treatment methods
IL161599A0 (en) Method for the treatment of over-active bladder
GB0104555D0 (en) New Therapeutic method
GB0126253D0 (en) Treatment method
GB0113156D0 (en) Diagnostic method
GB2413798B (en) Bioreactors for well treatment
AU2002367463A8 (en) Novel p53bp2 compounds for therapy and diagnosis and methods for using same
GB0102927D0 (en) Treatment method
GB0125105D0 (en) Method of treatment
GB0111487D0 (en) Method of treatment
GB0116029D0 (en) Method of treatment
GB0126094D0 (en) Method of treatment
GB0102559D0 (en) Treatment for angiogenesis-dependant condition
IL159259A0 (en) Methods using glycosaminoglycans for the treatment of nephropathy